| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2851915 | American Heart Journal | 2006 | 9 Pages |
Abstract
Although TNK with either enoxaparin or abciximab appeared to be more effective than with standard UHF in younger patients, these combinations tended to be less effective and even may be unsafe in the elderly. Development of new combination strategies and dosing schemes of fibrinolytics and antithrombotics with improved efficacy and safety in the elderly remains a high priority.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Peter R. MD, PhD, Yao PhD, Kris PhD, Alec MD, PhD, Jennifer MD, PhD, Paul W. MD, Lars MD, Frans J. MD, PhD, Christopher B. MD, on behalf of the ASSENT-3 and ASSENT-3 PLUS investigators on behalf of the ASSENT-3 and ASSENT-3 PLUS investigators,